Hyris

About:

Hyris is offers an integrated platform for decentralized nucleic acid testing Products.

Twitter/X: HyrisLtd

Top Investors: Astanor Ventures, Pi Campus

Description:

Hyris offers its partners and clients a disruptive platform that enables genetic testing of biological samples in any setting, at any time, with real time access to results on its dedicated cloud based software platform.

Total Funding Amount:

2.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2014-01-01

Contact Email:

office(AT)hyris.net

Founders:

Alberto Amati, Stefano Lo Priore

Number of Employees:

11-50

Last Funding Date:

2020-05-27

IPO Status:

Private

Industries: